FUSHILAI stated today on the interactive platform that the R-lipoic acid produced by the company's biocatalytic method has achieved mass production, mainly for external sales and the preparation of R-lipoic acid sodium salt. It is currently in the market promotion stage, and whether it can completely replace the original process depends on various factors such as market demand and customer acceptance